Australia markets closed

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1500+0.0700 (+6.48%)
At close: 04:00PM EDT
1.1400 -0.01 (-0.87%)
After hours: 07:30PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-101,167
-101,167
-93,867
-88,696
-62,131
Depreciation & amortisation
419
419
513
499
351
Stock-based compensation
8,687
8,687
5,199
6,180
5,428
Change in working capital
344
344
5,736
-1,498
-4,063
Accounts payable
1,234
1,234
3,425
1,166
1,031
Other working capital
-96,572
-96,572
-77,205
-71,520
-60,180
Other non-cash items
2,279
2,279
2,436
2,486
998
Net cash provided by operating activities
-96,512
-96,512
-77,102
-70,905
-58,818
Cash flows from investing activities
Investments in property, plant and equipment
-60
-60
-103
-615
-1,362
Purchases of investments
-16,823
-16,823
0
0
-
Sales/maturities of investments
2,000
2,000
0
0
-
Net cash used for investing activities
-14,883
-14,883
-103
-615
-1,362
Cash flows from financing activities
Debt repayment
-2,064
-2,064
-795
0
0
Common stock issued
59,999
59,999
122,631
75,985
-277
Common stock repurchased
0
0
0
-2,000
-277
Other financing activities
-631
-631
-4,814
-
-278
Net cash used provided by (used for) financing activities
88,516
88,516
117,230
74,245
12,394
Net change in cash
-22,780
-22,780
39,920
2,406
-47,384
Cash at beginning of period
123,028
123,028
83,108
80,702
128,086
Cash at end of period
100,248
100,248
123,028
83,108
80,702
Free cash flow
Operating cash flow
-96,512
-96,512
-77,102
-70,905
-58,818
Capital expenditure
-60
-60
-103
-615
-1,362
Free cash flow
-96,572
-96,572
-77,205
-71,520
-60,180